Advertisement

European Journal of Clinical Pharmacology

, Volume 25, Issue 3, pp 419–424 | Cite as

Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites

  • F. J. Rowell
  • R. A. Seymour
  • M. D. Rawlins
Originals

Summary

Serum concentrations of dihydrocodeine and its acid metabolites have been determined in seven human volunteers (6 male) who received the drug orally (30 mg and 60 mg) and intravenously (30 mg) on separate occasions, and in twenty-four patients (12 male) receiving 25 mg or 50 mg of the drug intravenously. The concentrations were estimated by radioimmunoassay on reconstituted extracts from serum after an extraction process which effectively separates dihydrocodeine from its polar acidic metabolites. The intravenous data show that dihydrocodeine kinetics followed a two-compartment distribution model. The concentration curves after oral administration indicated relatively rapid absorption with mean peak concentrations at 1.6h–1.8h. The mean half-lives varied between 3.3h–4.5h. From the AUC, the mean bioavailability of orally administered drug was 21% (range 12–34%). The peak levels of the acidic metabolites occurred between 1.8h–2.0h after oral administration and 2.2h–2.5h after i.v. administration, and they were significantly greater after oral administration. The low bioavailability of dihydrocodeine, together with the earlier and higher plasma levels of the acid metabolites after oral administration is suggestive of substantial first-pass metabolism.

Key words

dihydrocodeine pharmacokinetics acid metabolites radioimmunoassay bioavailability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aherne WG, Piali EM, Twycross RG (1979) Serum morphine concentrations after oral administration of diamorphine hydrochloride and morphine sulphate. Br J Clin Pharmacol 8: 557Google Scholar
  2. 2.
    Brown DR, Mannor JE (1978) ESTRIP a Basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691Google Scholar
  3. 3.
    Catlin DM (1977) Pharmacokinetics of morphine by radioimmunoassay: The influence of immunochemical factors. Pharmacol Exp Ther 200: 224Google Scholar
  4. 4.
    Findlay JWA, Butz RF, Welch RM (1977) Codeine kinetics as determined by radioimmunoassay. Clin Pharmacol Ther 22: 439Google Scholar
  5. 5.
    Misra AL (1978) Metabolism of opiates. In: Adler MW, Manara L, Samanin R (eds) Factors affecting the action of narcotics. Raven Press, New York, pp 297–343Google Scholar
  6. 6.
    Riggs DS (1972) The mathematical approach to physiological problems. M.I.T. Press, New YorkGoogle Scholar
  7. 7.
    Seymour RA, Rawlins MD, Rowell FJ (1982) Dihydrocodeine — induced hyperalgesia in postoperative dental pain. Lancet 1: 1425Google Scholar
  8. 8.
    Stanski RD, Greenblatt DJ, Lowenstein E (1978) Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 24: 52Google Scholar
  9. 9.
    Vaughan DP, Beckett AH (1973) The influence of reducing the C7–C8 double bond of codeine to give dihydrocodeine on the relative physiological availability of the drugs in man. J Pharm Pharmacol 25 [Suppl]: 104Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • F. J. Rowell
    • 1
    • 2
  • R. A. Seymour
    • 1
    • 2
  • M. D. Rawlins
    • 1
    • 2
  1. 1.Department of Pharmaceutical ChemistrySunderland PolytechnicSunderlandEngland
  2. 2.Department of Operative Dental Surgery, and Wolfson Unit of Clinical PharmacologyUniversity of Newcastle upon TyneNewcastle upon TyneEngland

Personalised recommendations